INCR.US InterCure Ltd.

Healthcare Biotechnology USA Stocks
3.79 USD
Close of Nov 15, 2026
3.12 7.55
Market cap
USD 49.2M
P/E
-
P/B
0.46x
ROE
-17.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2026.

Is INCR.US undervalued?

Graham number

The Graham number of InterCure Ltd. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

InterCure Ltd. fundamental analysis

No fundamental analysis for InterCure Ltd. yet.

InterCure Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About InterCure Ltd.

InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

Full company profile